VialsRX
“Tirzepatide and semaglutide are filled by VialsRX. NAD+, sermorelin and glutathione are filled by Hallandale Pharmacy. Both are licensed U.S. 503A pharmacies.”
PepHaūs Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.5/10
Best for: compounded semaglutide at one price for every dose, with the pharmacy named and DC covered
8.5
★★★★☆8.5/10
PepHaūs scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care. Its compounded semaglutide costs $169 a month, 15% below the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
$169/mo
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
See plans →See plans at PepHaūs →
Compare top-rated alternatives ↓Prices checked October 2026
PepHaus sells compounded semaglutide at $169 a month and compounded tirzepatide at $239, one price at any dose, with the provider visit, supplies and cold shipping included. Quarterly and 6-month plans, billed up front, lower that to $152 and $215 a month. VialsRX, a 503A pharmacy, fills both GLP-1s, and the site publishes a list of all 50 states plus DC. It also sells NAD+, sermorelin and glutathione injections.
By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
GLP-1 from $169/moPrice shown up frontFlat across dosesIncludes medication + consultAll 50 states and DCPharmacy namedNo FDA warning letters found
Is PepHaūs legit?
Yes. PepHaūs is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 8.5/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a PepHaūs promo or coupon code?
We know of no promo or coupon code for PepHaūs. Its listed price is $169 a month. Coupon sites advertising "PepHaūs discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how PepHaūs compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to PepHaūs
9.1/ 10
Verified partnerCollective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
★★★★★9.1/10
Editorial score · methodology
$59/mo+ membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →9.3/ 10
Verified partnerEmbody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
★★★★★9.3/10
Editorial score · methodology
$79/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full Embody review →7.9/ 10
Verified partnerLuvo Health
Best for: moving between compounded and brand without changing seller
★★★★☆7.9/10
Editorial score · methodology
$179/mo
CompoundedSemaglutideTirzepatideGonadorelinNAD+LegitScript Verified
Get StartedRead full Luvo Health review →PepHaūs at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $169/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states + DC
- FDA status
- No FDA warning letters found
How PepHaūs scores
Six columns, each one computed from something PepHaūs has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
6.2/10$169/month is 15% below the $199 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
10.0/10It names the pharmacy that fills its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states and DC.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
6weighted dimensions
734sellers compared
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on PepHaūs
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Recorded which pharmacies the seller names as filling its prescriptions, with the page and date
- Checked FDA warning letters for PepHaūs
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with PepHaūs involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1PepHaūs shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2VialsRX fills the prescriptions, and PepHaūs names it publicly, which most sellers do not.
- 3The monthly price includes the medication, clinician visits and shipping.
Price shown before you start
- Lowest ongoing monthly price: semaglutide $169, tirzepatide $239. That leaves out membership fees, first-month rates and insurance copays.
- PepHaūs serves all 50 states and DC.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting PepHaūs
- PepHaūs offers email support
Cancelling PepHaūs
Taken from the terms PepHaūs publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None on the monthly plan; quarterly and 6-month plans are billed up front
- Refund policy
- Full refund if canceled before the medication ships or if the provider declines; shipped medication cannot be returned
- Early-termination fee
- None
Medications PepHaūs lists
PepHaūs lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides PepHaūs offers
PepHaūs sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
Monthly plan, billed monthlyCompounded
$169/mo
semaglutide
One fixed price at any dose. Quarterly: $481.65 every 3 months ($160 a month). 6-month: $912.60 every 6 months ($152 a month).
Monthly plan, billed monthlyCompounded
$239/mo
tirzepatide
Quarterly plan $227 a month. 6-month plan: $1,291 billed up front ($215 a month).
Check the price yourself before you pay
Every figure here comes from PepHaūs's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
PepHaūs compounding-pharmacy partners
PepHaūs names each pharmacy below as one that compounds or fills its prescriptions, in its own site, terms or filings. The quote under each one is the seller’s own wording.
In its favor
- Semaglutide costs $169 a month, 15% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $239 a month, 11% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states and DC
- Names VialsRX as the pharmacy that fills its prescriptions, which most sellers do not
- We found no FDA warning letters issued to PepHaūs
Against it
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What PepHaūs charges
PepHaūs lists $169/month, flat regardless of dose. That sits at the affordable end of what we see. Flat dose pricing matters more than it sounds: on a tiered plan the bill grows with the dose, so the figure that got you to sign up is not the one you end up paying.
- Compounded semaglutide: $169/month
- Compounded tirzepatide: $239/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so PepHaūs' $169 is genuinely below the middle, not just advertised that way. Before you pay, compare PepHaūs' cancellation terms with other sellers' cancellation and refund policies. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.
MEDGm, at about $169/month, is the closest like-for-like alternative we review.
What PepHaūs dispenses
PepHaūs prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.
Safety and disclosure
PepHaūs tells you its price before you start the medical questionnaire, that it treats patients in all 50 states, the pharmacy that fills its prescriptions, and that its pharmacy is accredited. We found no FDA warning letters issued to PepHaūs. Because the medication is compounded, the named pharmacy is the detail that matters most: its license is the one you can look up. The FDA publishes seven warning signs for telehealth medicine sellers, and they take a minute to run against PepHaūs. How we weigh oversight, disclosure and price is set out in our scoring methodology.
PepHaūs also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether PepHaūs bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
- you need access wherever you live
Our read
PepHaūs competes on price without an obvious sacrifice elsewhere: $169/month, no FDA warning letters, and wide state coverage.
The Bottom Line
PepHaūs scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care. Its compounded semaglutide costs $169 a month, 15% below the $199 median among the sellers we compare.
Score: 8.5/10Best for: compounded semaglutide at one price for every dose, with the pharmacy named and DC coveredFrom: $169/mo
Before you pay PepHaūs
Starting at $169 a month. Check today's price, then start the intake.
Where PepHaūs is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to PepHaūs sets more sellers in the same category beside PepHaūs on price, states and what the price includes.
Frequently Asked Questions
PepHaus sells compounded semaglutide at $169 a month and compounded tirzepatide at $239, one price at any dose, with the provider visit, supplies and cold shipping included. Quarterly and 6-month plans, billed up front, lower that to $152 and $215 a month. VialsRX, a 503A pharmacy, fills both GLP-1s, and the site publishes a list of all 50 states plus DC. It also sells NAD+, sermorelin and glutathione injections. We rate it 8.5/10 overall.
PepHaūs starts at $169 a month. That number holds across doses, so titrating up does not move the bill. The pricing table above lists every tier.
PepHaūs says it treats patients in all 50 states.
PepHaūs lists compounded semaglutide and compounded tirzepatide.
PepHaūs lists compounded GLP-1s only. A licensed compounding pharmacy prepares them: same active ingredient as the brand drug, lower cash price, and no FDA approval of the finished product. That last part is the one readers underestimate, and the review above says why.
Check whether PepHaūs bills your insurance before you sign up. Compounded GLP-1s are rarely covered by insurance, so plan on paying the listed cash price.
PepHaūs says the price covers medication, the clinician visit and shipping. The strip near the top of this review shows what is included and what is not.
You fill in an online intake, a licensed clinician decides whether a GLP-1 is appropriate, and if the answer is yes the medication ships to you. PepHaūs runs that whole sequence on its own site.
We found no FDA warning letters issued to PepHaūs. Before you buy, weigh these: Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality. None of them rules PepHaūs out, but each is worth settling before you pay.
Other sellers we cover include MEDGm, MyDrHank, and HealthRX. Which one fits depends on the medication, the monthly price you can sustain and whether it ships to your state, so compare those three facts before you switch.
How to check PepHaūs yourself
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
- How to Get a GLP-1 Prescription
- FDA Warning Letters to Peptide Sellers: What FDA Has Cited, 2023 to 2026
Every seller that ships to your state, side by side: Arizona, Illinois, Indiana, Montana, New Hampshire, Rhode Island, Virginia, Wyoming and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this PepHaūs review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See PepHaūs's current pricing
Plans start at $169 a month. Whether you qualify is a clinician's decision, made after your intake.
Not sold on PepHaūs?
Vetted alternatives